These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2720993)

  • 1. Effect of storage temperature on concentrations of digoxin-like immunoreactive factor(s) in plasma.
    Krivoy N; Jakobi P
    Clin Chem; 1989 May; 35(5):895-6. PubMed ID: 2720993
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin].
    Baz MJ; Vargas F; Haro JM; Castillo MA; Jódar E; Andrade JL; García del Río C
    Rev Esp Fisiol; 1990 Dec; 46(4):385-91. PubMed ID: 2099536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin-like immunoreactivity in saliva and plasma of pregnant women.
    Jakobi P; Krivoy N; Schwartz K; Ben Aryeh H; Laufer D
    Clin Chem; 1991 Jan; 37(1):135-6. PubMed ID: 1988202
    [No Abstract]   [Full Text] [Related]  

  • 6. Temperature-dependent immunoreactive assay to screen for digoxin-like immunoreactive factor(s).
    Guédeney X; Chanez C; Grenier A; Scherrmann JM
    Clin Chem; 1991 Nov; 37(11):1900-4. PubMed ID: 1718632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
    Yannakou L; Diamandis EP; Souvatzoglou A
    Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 10. Digoxin-like immunoreactive factor(s) in human gonadotropin stimulated follicular fluid.
    Jakobi P; Krivoy N; Eibschitz I; Ziskind G; Barzilai D; Paldi E
    J Clin Endocrinol Metab; 1989 Jul; 69(1):209-11. PubMed ID: 2499591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
    Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
    Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
    Jakobi P; Krivoy N; Weissman A; Paldi E
    Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin-like immunoreactive factor and premature labour.
    Goodlin RC
    Lancet; 1987 Jan; 1(8524):102-3. PubMed ID: 2879153
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous digitalis-like factors.
    Graves SW
    Crit Rev Clin Lab Sci; 1986; 23(3):177-200. PubMed ID: 3015491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin-like immunoreactive factor and respiratory distress syndrome.
    Goodlin RC
    Am J Obstet Gynecol; 1990 Sep; 163(3):1091. PubMed ID: 2403136
    [No Abstract]   [Full Text] [Related]  

  • 16. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous digoxin-like immunoreactivity in follicular fluid and in vitro fertilization.
    Jakobi P; Krivoy N; Eibschitz I; Ziskind G
    Gynecol Obstet Invest; 1991; 32(4):193-5. PubMed ID: 1663910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of progesterone and cortisol as immunoreactive plasma digitalis like factors in pregnancy.
    Longerich L; Brent DA; Johnson RL; Vasdev S; Gault MH
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):383-93. PubMed ID: 2834807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.